Background: The incidence of melanoma is still increasing in fair-skinned populations. At least 80% of patients have localised disease and expect a 5-year relative survival of >90%. Results: A response rate of 72% was achieved from a total of 1085 distributed questionnaires. Hundred and seventeen questionnaires had to be excluded because of updated information about secondary tumour and progression events. Thus, questionnaires from 664 patients were evaluated. QoL scores in melanoma patients were essentially similar to those of a general population. Differences were detected between women and men concerning emotional and sexual functioning. Age and number of comorbidities were the strongest factors influencing most all aspects of QoL. Fifty percent of patients referred to deficits in communication with their doctors.
The incidence of malignant melanoma is still increasing in fairskinned populations. In 2004, 6% of male and 5% of female cancer cases in a white, non-Hispanic USA population were melanomas and these proportions have since increased [1] . In Germany, melanoma contributes to 2.8% of all male and 4.1% of all female cancer cases [2] .
In the United States, the 5-year relative survival is 91% in non-Hispanic whites. About 80% of melanoma patients are diagnosed in a localised stage, which has an even better survival [1] . In a German cohort, the 5-year relative survival of all melanoma patients is comparable [3] . Thus, a considerable amount of patients face a life-threatening but curable disease, often without any physical deficits.
Quality-of-life (QoL) assessment has become standard in many clinical studies on cancer patients. The cancer patient's QoL is a product of many patient-specific factors, such as a person's previous QoL, their ability to cope with the disease and a supportive environment. Associations between QoL and survival were found in advanced malignant melanoma, which led to the recommendation to improve QoL for prolonging survival [4] . QoL and the influence of several immunotherapy or chemotherapy regimens have been studied in advanced and high-risk malignant melanoma [4] [5] [6] [7] [8] [9] [10] [11] . Despite some specific problems concerning physical functioning, QoL results for long-term survivors after isolated limb perfusion were observed as good as, or better than, for the general population [12] . A recently published review concludes that QoL impairment in melanoma patients is comparable with other cancers, but most of the published studies comprise only small patient numbers [13] . The objective of the current study is to present QoL data from a population-based cohort of melanoma patients after treatment with curative intent and the cessation of treatmentrelated acute side-effects.
patients and methods

patient recruitment
The Munich Cancer Registry (MCR) conducted this study in conjunction with the three departments of dermatology in the associated cancer registration area, where the MCR routinely records all cancer patients. At the time of this study, the population size was 2.3 million. The MCR systematically registered all solid tumours from reports of all pathology laboratories including the main prognostic factors as TNM (tumour-node-metastasis) stage, histology, lymph node status, Clark's level, tumour thickness and resection margins. In parallel with these data, standardised forms concerning patients' domicile, tumour diagnosis, primary therapy, follow-up and palliative care are completed by the clinicians. Progression and life status are monitored through follow-up, which are maintained systematically through death certificates and information from the Citizen's Registry office.
All MCR data are registered according to International Agency for Research on Cancer recommendations [14, 15] .
The present study was nested within this infrastructure of the MCR and was approved by the ethic committee of the Medical Faculty of the Ludwig-Maximilians-University Munich before beginning.
Patients were recruited in 2003 and 2004. Inclusion criteria were an initial diagnosis of melanoma without distant metastasis 21-24 months before the study, the absence of disease progression at time of questionnaire administration and the ability to read German. Questionnaires were sent on behalf of the treating clinicians to the eligible patients in January and 
patient questionnaire
The patient questionnaire consisted of three sections. The first part established information about comorbidities within the last year, with a list of common chronic diseases as well as sociodemographic details including marital status, education, employment and medical insurance. The European Organisation for Research and Treatment of Cancer (EORTC) Quality of Life Questionnaire QLQ-C30, a reliable and validated QoL evaluation tool, made up the second part [16] . This tool aggregates 30 questions to five functional scales (physical, role, cognitive, emotional and social functioning), a global QoL measure and symptom scales including pain, fatigue, etc. [17] . Additional questions addressing body image, sexual functioning and future health worries were extracted from the EORTC breast cancer-specific questionnaire QLQ-BR-23 (scales 'Body Image', 'Sexual Functioning', 'Sexual Enjoyment' generated with questions No. 9, 10, 12-16). The scale values can range from 0 to 100. Higher scores in functioning scales represent higher functioning abilities and better QoL. Higher scores in symptom scales represent more symptoms and worse QoL. The third part included the assessment of patients' satisfaction with their hospitalisation and doctor communication according to former studies in rectal and breast cancer patients [18, 19] . Patients were asked to indicate whether the information they received concerning seven core communication elements (illness, medical examinations, treatment, recovery, diagnosis, prognosis and side-effects) was comprehensible and complete or not. Additional information about social support, coping with the disease and positive or negative life changes were extracted from the 'Mental Adjustment to Cancer' Scale [20] and the 'Functional Assessment of Cancer Therapy-General' Scale [21] . These questions are presented in Table 3 .
statistical analyses
All statistical analyses were run in SAS (Statistical Analysis System, Release 9.1). The significance level a was set at 0.05. The QoL responses were aggregated and transformed according to the EORTC guidelines [22] . The v 2 -test and Student's t-test were conducted to indicate the clinical, demographic and gender differences considering communication needs, social support, coping with the disease and lifestyle. Differences in QoL scores were analysed by Mann-Whitney U and Kruskal-Wallis H tests as recommended [23] . Thereafter, the EORTC QLQ functioning scores were median dichotomised [24] for logistic regression analyses assessing clinical and demographic predictors of bad QoL. This procedure should ensure that the targeted group (patients with lower QoL) was not too small. Patients with a QoL score below the median were given a value '1', while those whose scores were equal or greater than the median were assigned the value '0'. Each QoL score was entered separately as the dependent variable in a logistic regression analysis. 
results
Questionnaires were received from a total of 781 (72%) study participants. Due to updated data indicating secondary tumours and progression events before administration of the questionnaire, 117 patient responses had to be excluded. Thus, 664 patients, 348 women and 316 men, were included. Clinical and demographic characteristics are presented in Table 1 . On average, women and men were 5 and 3 years younger, respectively, than the total cohort of melanoma patients in the MCR [3] . Women were younger, had thinner tumours and more tumours in their extremities than men. Lymph node dissection and immunotherapy were conducted less frequently in women than in men. Men were more often married and had a higher level of education than women.
The EORTC functioning and symptom scores are shown in Table 2 . Women and men were significantly different in emotional and sexual functioning and the symptoms insomnia, constipation and diarrhoea: women had lower functioning scores and higher symptom scores of insomnia and constipation and men had higher diarrhoea scores. Figure 1 shows the mostly significant associations between age and QoL scores and between comorbidities and QoL. Younger age correlated overall with better functioning and symptom scores. Exceptions were emotional functioning and body image, which were better in the elderly. Social functioning and 'worry about the future' showed no significant association with age. In addition to increasing age, the increasing absolute number of comorbidities was associated with worse functioning scores, increased symptom scores and more worries about the future. Table 3 presents the communication needs, social support, coping strategies, lifestyle and positive outcome. More communication with any person, who was involved in treatment, care and attendance of the melanoma patient, was desired by two-thirds of participants. Significantly more women than men desired to speak more to family members, other cancer patients, nurses or non-medical staff. More than 50% of the participants felt incompletely informed about their illness. Almost half of all study participants (47%) indicated that their doctors did not ask about their ability to cope with their disease.
Women felt significantly more supported by their friends, while men felt supported by their family. Eighty percent of the participants indicated that they have maintained a positive attitude towards life. Nevertheless, 31% of all patients felt that they have no control over procedures concerning their illness and 42% worried about a relapse.
Between 40% and 50% of patients reported that their attitude towards life and other aspects of lifestyle had changed for the better since the disease diagnosis. The only significant difference between women and men was found concerning 'attitude towards life', which changed for the better in more women than men. Table 4 shows multivariate logistic regression analyses modelling the QoL functioning scores. A significant predictor of all functioning scores is the number of comorbidities; the greater the number of comorbidities, the worse all other scores are. Age, as well, is a significant predictor of all scores except for role functioning. The elderly, especially those ‡70 years, have worse physical and cognitive functioning and global QoL compared with those <40 years but better QoL scores concerning all other conditions. Female gender was associated with worse emotional functioning. Variables describing tumour stage have significant influences in every model: tumour thickness >2 mm leads to a nearly threefold risk of experiencing bad physical functioning, and a stage of pN+ is associated with a higher risk of bad role, emotional and social functioning as well as global QoL (between 250% and 450%). Having undergone lymph node dissection leads to bad QoL as measured by the role functioning, body image and 'worry about the future' scale. The effect of lymph node dissection may describe tumour stage as well as residual effects of surgical therapy. This may be the case particularly in the role functioning and body image scales. However, these variables show overlaying effects, so that the regression models do not imply all three of them. Good communication during the disease significantly enhanced emotional and social functioning and body image. discussion QoL in melanoma patients, without recurrence within 2 years after initial therapy, is comparable with QoL in a general German population [25] . The scores of physical, role and emotional functioning as well as global QoL are similar to those of an even younger, normal population. Lower scores were observed in cognitive and social functioning. The abovementioned German general population shows significant associations between increasing age and decreasing physical, role and cognitive functioning. Gender differences in functioning scores are small. Only emotional functioning was worse in women than in men (P < 0.05). Considering the symptom scores, women had significantly more complaints about sleep loss and constipation, whereas men reported more problems with diarrhoea. This corresponds to findings in the previously mentioned German population as well as to those in Swedish and Norwegian general population samples [26, 27] .
Age and number of comorbidities showed strong associations with QoL. With increasing age, the physical, role and cognitive functioning scores decreased, whereas emotional functioning and body image increased. Most symptom scores rose with increasing age (e.g. fatigue, pain, insomnia, appetite loss and constipation). This corresponds to the previously mentioned German, Swedish and Norwegian general populations. As in the Swedish general population [26] , comorbidity leads to lower functioning and higher symptom scores, in the melanoma patient sample.
The logistic regression analyses confirm the influence of age on all functioning aspects of QoL. The only influence of gender was found with regard to emotional functioning.
Regardless of the kind of disease and in parallel to age, the number of comorbidities has great influence on all functioning scores with a significant linear trend. Thus, comorbidities remain a major determinant of distress that can influence QoL, even after a malignant disease [28] .
Patient communication within the medical system was another important factor. Those who estimated their communication to be good had significantly better emotional and social functioning, better body image and less worry about future. Similar results were found in breast cancer [19] and rectal cancer patients [18] .
Nonetheless, 53% of participants felt that information concerning their illness was incomplete. It cannot be determined whether positively experienced communication influenced the QoL in a positive way or whether the patients with lower QoL complained more since QoL and experienced communication are both study outcomes. Regardless, improvement in communication between patients and medical staff may be an approach to improve QoL in melanoma patients. Specifically, the doctor to patient communication, which 25% of patients wished to be expanded, could be improved. Communication needs between women and men differed significantly considering the overall rating and the contact persons sought during their illness. More men than women rated the communication as good overall (79.4% of men and 71% of women). More women than men indicated a need for more dialogue with their family members, other cancer patients and psychologists. About 51% of women and 42% of men complained about not being asked by their doctor about coping with the disease. Thus, there may be a need for doctors in training to learn to be more empathetic.
In general, 75% of the patients received social support from their families. Significantly more women felt close to their friends (77% of women, 67% of men) and received psychological support from them (66% of women, 53% of Annals of Oncology original article men). Otherwise, significantly more men than women felt close to their nearest partner (94% of men, 87% of women) and were content with their family's conversation about the disease (90% of men, 80% of women). Similar gender differences were found in a Finnish study [28] . It has also been shown by recent meta-analysis that women may not find as much comfort or support from their families as men do [29] . In couples, the female partner always reported more distress, regardless if she herself was the patient or the patient's partner.
A half of the melanoma patients reported a change for better in their attitude towards life. Dirksen [30] found the same results with reappraisal and change in self-awareness, reordering of priorities and a sense of living for today in 52% of her long-term surviving melanoma patients. Melanoma patients without relapse appear to experience a melange of physical and psychological processes which result in QoL scores similar to those observed in general populations. Thus, in melanoma patients, coping strategies used to deal with their original article 
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